TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Psycho-social Support Training by School Teachers on Improving Mental Health and Hope of School Going Adolescents in Earthquake Affected Districts in Nepal
Brief Summary: Adolescents are prone to mental health problems such as post-traumatic stress disorder (PTSD) and depression which could become worse in the aftermath of disasters. However, hope can help adolescents cope with the challenges better. For resource poor disaster prone settings, school teachers can provide timely psycho-social support that could improve mental health and hope among adolescents.

Nepal is a disaster prone country that faced a devastating earthquake in 2015 that claimed thousands of lives and left many homeless which could have affected the mental health of adolescents.This study was conducted in schools of Dhading, a severely earthquake affected district and schools of Myagdi, a least affected district by earthquake in Nepal. The intervention focused on training school teachers on psycho-social support for adolescents.


Options:
A: Arm Label: Step-by-Step; Type: EXPERIMENTAL; Interventions: Behavioral: Step-by-Step | Arm Label: Enhanced care as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced care as usual | Intervention Type: BEHAVIORAL; Name: Step-by-Step; Assigned to Arm(s): Step-by-Step | Intervention Type: BEHAVIORAL; Name: Enhanced care as usual; Assigned to Arm(s): Enhanced care as usual
B: Arm Label: Wait List Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Trauma Focused Cognitive Behavioral Therapy | Intervention Type: BEHAVIORAL; Name: Trauma Focused Cognitive Behavioral Therapy; Assigned to Arm(s): Intervention Group
C: Arm Label: Active intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physiotherapy activity and awareness intervention: PAAI, Behavioral: Psychological intervention: Teaching recovery techniques (TRT) | Arm Label: Waiting list; Type: EXPERIMENTAL; Interventions: Behavioral: Physiotherapy activity and awareness intervention: PAAI, Behavioral: Psychological intervention: Teaching recovery techniques (TRT) | Intervention Type: BEHAVIORAL; Name: Physiotherapy activity and awareness intervention: PAAI; Assigned to Arm(s): Active intervention, Waiting list | Intervention Type: BEHAVIORAL; Name: Psychological intervention: Teaching recovery techniques (TRT); Assigned to Arm(s): Active intervention, Waiting list
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial support training for school teachers | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial support training for school teachers; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Psycho-social Support Training by School Teachers on Improving Mental Health and Hope of School Going Adolescents in Earthquake Affected Districts in Nepal
Brief Summary: Adolescents are prone to mental health problems such as post-traumatic stress disorder (PTSD) and depression which could become worse in the aftermath of disasters. However, hope can help adolescents cope with the challenges better. For resource poor disaster prone settings, school teachers can provide timely psycho-social support that could improve mental health and hope among adolescents.

Nepal is a disaster prone country that faced a devastating earthquake in 2015 that claimed thousands of lives and left many homeless which could have affected the mental health of adolescents.This study was conducted in schools of Dhading, a severely earthquake affected district and schools of Myagdi, a least affected district by earthquake in Nepal. The intervention focused on training school teachers on psycho-social support for adolescents.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial support training for school teachers | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial support training for school teachers; Assigned to Arm(s): Intervention
B: Arm Label: Group problem management plus; Type: EXPERIMENTAL; Interventions: Behavioral: Group problem management plus | Arm Label: Enhanced treatment as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Group problem management plus, Behavioral: Enhanced treatment as usual | Intervention Type: BEHAVIORAL; Name: Group problem management plus; Assigned to Arm(s): Enhanced treatment as usual, Group problem management plus | Intervention Type: BEHAVIORAL; Name: Enhanced treatment as usual; Assigned to Arm(s): Enhanced treatment as usual
C: Arm Label: Early Childhood Development Program; Type: EXPERIMENTAL; Interventions: Behavioral: Early Childhood Development Program | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Early Childhood Development Program; Assigned to Arm(s): Early Childhood Development Program
D: Arm Label: ARM 1: Component-Based Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Common Elements Treatment Approach | Arm Label: ARM 2: Community Group Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Narrative Community Group Therapy | Arm Label: ARM 3: Standby group; Type: OTHER; Interventions: Other: Standby group | Intervention Type: BEHAVIORAL; Name: Common Elements Treatment Approach; Assigned to Arm(s): ARM 1: Component-Based Intervention | Intervention Type: BEHAVIORAL; Name: Narrative Community Group Therapy; Assigned to Arm(s): ARM 2: Community Group Therapy | Intervention Type: OTHER; Name: Standby group; Assigned to Arm(s): ARM 3: Standby group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection in the Management of Actively Bleeding Esophageal Varices
Brief Summary: Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection


Options:
A: Arm Label: EVL plus Somatostatin; Type: EXPERIMENTAL; Interventions: Drug: Somatostatin | Arm Label: EVL plus Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Somatostatin; Assigned to Arm(s): EVL plus Somatostatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): EVL plus Placebo
B: Intervention Type: PROCEDURE; Name: Transjugular Intrahepatic Portosystemic Shunt (TIPS); Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Distal Splenorenal Shunt; Assigned to Arm(s): N/A
C: Arm Label: Injection Sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Injection Sclerotherapy | Arm Label: N-butyl-2-cyanoacrylate; Type: ACTIVE_COMPARATOR; Interventions: Drug: N-butyl-2-cyanoacrylate | Intervention Type: DRUG; Name: Injection Sclerotherapy; Assigned to Arm(s): Injection Sclerotherapy | Intervention Type: DRUG; Name: N-butyl-2-cyanoacrylate; Assigned to Arm(s): N-butyl-2-cyanoacrylate
D: Arm Label: Portacaval shunt; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Portacaval shunt | Arm Label: Sclerotherapy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Sclerotherapy | Intervention Type: PROCEDURE; Name: Portacaval shunt; Assigned to Arm(s): Portacaval shunt | Intervention Type: PROCEDURE; Name: Sclerotherapy; Assigned to Arm(s): Sclerotherapy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Study to Describe the Glycaemic Variability of Insulin Glargine 300U/ml Versus NPH (Neutral Protamine Hagedorn) in the Insulin-naïve Type 2 Diabetes Patients Following a Patient-adjusted Insulin Algorithm in Hong Kong
Brief Summary: This is a 24 week, multicentre, prospective, randomized, controlled, parallel-designed (1:1) pilot study.The study will compare glycemic variability in patients treated with insulin glargine U300/ml insulin versus conventional (NPH) insulin using a self titration algorithm.50 type 2 diabetes patients who are newly started on insulin will be recruited. They will be randomly allocated to either insulin glargine U300 or NPH insulin for 26 weeks. All subjects will follow a insulin-self titration algorithm. The study will consist of 9 visits over 26 weeks. Blood glucose variability will be collected by CGM for 7 consecutive days at baseline (week -1) and at week 24.Secondary endpoints other than data on glycemic variability, including HbA1c, fasting plasma glucose, inflammatory markers will be measured during three periods (week 0, week 12 and week 24).


Options:
A: Arm Label: Active; Type: EXPERIMENTAL; Interventions: Drug: Insulin Glargine 300 UNT/ML | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Neutral protamine hagedorn insulin | Intervention Type: DRUG; Name: Insulin Glargine 300 UNT/ML; Assigned to Arm(s): Active | Intervention Type: DRUG; Name: Neutral protamine hagedorn insulin; Assigned to Arm(s): Control
B: Arm Label: 1. Insulatard; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulatard | Arm Label: 2. Detemir; Type: ACTIVE_COMPARATOR; Interventions: Drug: Detemir | Intervention Type: DRUG; Name: Insulatard; Assigned to Arm(s): 1. Insulatard | Intervention Type: DRUG; Name: Detemir; Assigned to Arm(s): 2. Detemir
C: Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: insulin NPH; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: insulin detemir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: insulin NPH; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: insulin aspart; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Cortical Pain Processing in Full Term Infants, After Giving Different Non-pharmacological Analgesia
Brief Summary: Minor painful procedures are frequently performed on newborn infants and non-pharmacological analgesia is commonly used. As more than one analgesic method may be applied simultaneously in clinical practice, the relative contribution and efficacy of analgesic components still needs to be further elucidated. In the present study neonatal cortical brain response during four types of non-pharmacological analgesia (oral glucose, expressed breastmilk, maternal holding plus oral glucose, maternal holding plus breastfeeding) will be studied. The aim is to assess the differential effect of oral solutions (glucose, breastmilk), when given alone or in combination with maternal relationship (holding, breastfeeding). The study will test the hypothesis that the mother-infant relationship would improve the analgesic effect of oral solutions.


Options:
A: Arm Label: Oral glucose solution + maternal holding; Type: EXPERIMENTAL; Interventions: Other: Oral glucose solution + maternal holding | Arm Label: Breastfeeding; Type: EXPERIMENTAL; Interventions: Other: Breastfeeding | Arm Label: Oral glucose solution; Type: ACTIVE_COMPARATOR; Interventions: Other: Oral glucose solution | Arm Label: Oral expressed breastmilk; Type: ACTIVE_COMPARATOR; Interventions: Other: Oral expressed breastmilk | Intervention Type: OTHER; Name: Oral glucose solution + maternal holding; Assigned to Arm(s): Oral glucose solution + maternal holding | Intervention Type: OTHER; Name: Breastfeeding; Assigned to Arm(s): Breastfeeding | Intervention Type: OTHER; Name: Oral glucose solution; Assigned to Arm(s): Oral glucose solution | Intervention Type: OTHER; Name: Oral expressed breastmilk; Assigned to Arm(s): Oral expressed breastmilk
B: N/A
C: Arm Label: Breast Milk; Type: ACTIVE_COMPARATOR; Interventions: Other: Breast Human Milk | Arm Label: 24 %Sucrose; Type: OTHER; Interventions: Other: 24 % Sucrose | Intervention Type: OTHER; Name: Breast Human Milk; Assigned to Arm(s): Breast Milk | Intervention Type: OTHER; Name: 24 % Sucrose; Assigned to Arm(s): 24 %Sucrose
D: Intervention Type: DRUG; Name: Sucrose solution 30%1 ml; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Breastfeeding; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Home Care for the Patient With Heart Failure: Can Caregiver Education Prevent Hospital Admissions? A Clinical Randomized Trial.
Brief Summary: The study is aimed to evaluate if the education of the caregiver is able to reduce hospital admissions of patients with heart failure assisted at home.


Options:
A: Arm Label: Lifestyle counselling; Type: EXPERIMENTAL; Interventions: Other: Disease management program | Arm Label: Comparator; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: OTHER; Name: Disease management program; Assigned to Arm(s): Lifestyle counselling | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Comparator
B: Arm Label: Peer-mentoring; Type: EXPERIMENTAL; Interventions: Other: Peer-mentoring | Intervention Type: OTHER; Name: Peer-mentoring; Assigned to Arm(s): Peer-mentoring
C: Arm Label: Facebook group; Type: EXPERIMENTAL; Interventions: Behavioral: Facebook | Arm Label: Comparison group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Facebook | Intervention Type: BEHAVIORAL; Name: Facebook; Assigned to Arm(s): Comparison group, Facebook group
D: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Education | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy of Penile Traction Therapy Using a Novel Device: A Controlled, Single-blinded, Randomized Trial
Brief Summary: This clinical trial is designed to assess the safety, dosing, and preliminary efficacy of a novel penile traction device on correcting deformities relating to Peyronie's disease, a condition which results in penile curvature and length loss. The trial is designed as a randomized, placebo-controlled study with men randomized to receiving no therapy or penile traction therapy 30 minutes once, twice, or three times daily. The study will occur over a 3 month period, after which an open label phase for 3 months will be conducted. Final assessments for adverse effects will also be assessed at 9 months.


Options:
A: Arm Label: AA4500; Type: EXPERIMENTAL; Interventions: Biological: AA4500 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: AA4500; Assigned to Arm(s): AA4500 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: AA4500; Type: EXPERIMENTAL; Interventions: Biological: AA4500 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo | Intervention Type: BIOLOGICAL; Name: AA4500; Assigned to Arm(s): AA4500 | Intervention Type: BIOLOGICAL; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: AA4500; Type: EXPERIMENTAL; Interventions: Biological: AA4500 | Intervention Type: BIOLOGICAL; Name: AA4500; Assigned to Arm(s): AA4500
D: Arm Label: Group 1 - Control; Type: SHAM_COMPARATOR; Interventions: Device: RestoreX PTT - open label phase only | Arm Label: Group 2 - PTT 1x daily x 3 months; Type: EXPERIMENTAL; Interventions: Device: RestoreX PTT - randomized and open label | Arm Label: Group 3 - PTT 2x daily x 3 months; Type: EXPERIMENTAL; Interventions: Device: RestoreX PTT - randomized and open label | Arm Label: Group 4 - PTT 3x daily x 3 months; Type: EXPERIMENTAL; Interventions: Device: RestoreX PTT - randomized and open label | Intervention Type: DEVICE; Name: RestoreX PTT - randomized and open label; Assigned to Arm(s): Group 2 - PTT 1x daily x 3 months, Group 3 - PTT 2x daily x 3 months, Group 4 - PTT 3x daily x 3 months | Intervention Type: DEVICE; Name: RestoreX PTT - open label phase only; Assigned to Arm(s): Group 1 - Control

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Working Within an Integrated Learning Healthcare System to Improve Living Kidney Donation Knowledge Across the CKD Continuum for All Racial Groups
Brief Summary: Today, there are 25 million Americans with chronic kidney disease (CKD) and 660,000 patients in full kidney failure, the final CKD stage, known as end stage renal disease (ESRD). Over half of ESRD patients are Black, Hispanic, or Asian. ESRD patients must either receive regular dialysis treatments, by which waste is filtered from the blood by a machine, or a kidney transplant from a deceased or living donor. Five-year survival on dialysis is only 40%, compared to 74% with a deceased donor kidney transplant (DDKT) and 87% with a living donor kidney transplant (LDKT). Despite the known health benefits of DDKT and LDKT, 70% of ESRD patients remain on dialysis, especially ethnic/racial minorities.

An American Society of Transplantation (AST) Consensus Conference recently recommended that patients in all CKD stages should have the opportunity to learn about and decide which treatment option is right for them, particularly about LDKT. However, early education about LDKT and DDKT is inconsistent and often poor, with early stage CKD patients and ethnic/racial minorities even less likely to receive it.

Through previous HRSA grants, Dr. Waterman designed the Explore Transplant@Home (ET@Home) video-guided education program, and found that it significantly increased LDKT knowledge and informed decision-making for Black and White dialysis patients in Missouri when delivered by mail and supported through bimonthly postcards and texting. Now based at the University of California, Los Angeles (UCLA), she has partnered with Kaiser Permanente Southern California (KPSC), an integrated learning healthcare system providing insurance coverage and comprehensive care to 65,000 patients in CKD Stages 3, 4 and 5 (ESRD) (24% Hispanic, 52% White, 15% Black, and 9% Asian; 10% Spanish-speaking).


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control | Intervention Type: BEHAVIORAL; Name: Intervention; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): 2
B: Arm Label: Standard of Care (Control); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Patient-Guided; Type: EXPERIMENTAL; Interventions: Behavioral: Patient-Guided | Intervention Type: BEHAVIORAL; Name: Patient-Guided; Assigned to Arm(s): Patient-Guided
C: Arm Label: Behavioral; Type: EXPERIMENTAL; Interventions: Behavioral: Behavioural Lifestyle Intervention | Arm Label: Enhanced usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Behavioural Lifestyle Intervention; Assigned to Arm(s): Behavioral
D: Arm Label: Salud al Día; Type: EXPERIMENTAL; Interventions: Behavioral: Salud al Día | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Salud al Día; Assigned to Arm(s): Salud al Día

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Self-Management of Breast and Nipple Pain in Breastfeeding Women
Brief Summary: This pilot project will provide an understanding of the contextual variables responsible for breast and nipple pain during breastfeeding initiation. These variables include, genetic variation, pain sensitivity, reactivity, pain catastrophizing and perceived stress. The purpose is to understand the efficacy of self-management (SM) strategies on each of these contextual variables, in an effort to inform a personalized approach to managing breastfeeding pain and its effect on improved health outcomes.


Options:
A: Arm Label: Self-monitoring of BF and intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring of BF and intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-monitoring of BF and intervention; Assigned to Arm(s): Self-monitoring of BF and intervention
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: LC and Electronic Prompt | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: LC and Electronic Prompt; Assigned to Arm(s): 1
C: Arm Label: Essential Health Care (EHC) only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Mass media | Arm Label: EHC + Micronutrient Powders; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Arm Label: EHC + BCC; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Behavioral: Mass media | Arm Label: EHC + BCC + Micronutrient powders; Type: EXPERIMENTAL; Interventions: Behavioral: EHC + BCC, Dietary Supplement: Micronutrient powders, Behavioral: Mass media | Intervention Type: BEHAVIORAL; Name: EHC + BCC; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient powders; Assigned to Arm(s): EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders | Intervention Type: BEHAVIORAL; Name: Mass media; Assigned to Arm(s): EHC + BCC, EHC + BCC + Micronutrient powders, EHC + Micronutrient Powders, Essential Health Care (EHC) only
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary Advice | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Dietary Advice; Assigned to Arm(s): Intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Promoting Self-Management of Breast and Nipple Pain in Breastfeeding Women
Brief Summary: This pilot project will provide an understanding of the contextual variables responsible for breast and nipple pain during breastfeeding initiation. These variables include, genetic variation, pain sensitivity, reactivity, pain catastrophizing and perceived stress. The purpose is to understand the efficacy of self-management (SM) strategies on each of these contextual variables, in an effort to inform a personalized approach to managing breastfeeding pain and its effect on improved health outcomes.


Options:
A: Intervention Type: PROCEDURE; Name: Percutaneous Suprapubic Aspiration; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Urethral Catheterization; Assigned to Arm(s): N/A
B: Arm Label: Before Hidrotherapy; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Hidrotherapy; Type: EXPERIMENTAL; Interventions: Other: Aquatic Physical Therapy | Intervention Type: OTHER; Name: Aquatic Physical Therapy; Assigned to Arm(s): Hidrotherapy
C: Arm Label: Self-monitoring of BF and intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Self-monitoring of BF and intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Self-monitoring of BF and intervention; Assigned to Arm(s): Self-monitoring of BF and intervention
D: N/A

Answer: C